
In a study involving 403 early-stage cervical cancer patients without high-risk factors, researchers compared postoperative concurrent radiochemotherapy (CCRT) with radiotherapy (RT) alone. Patients were categorized into intermediate-risk and low-risk groups. Results showed no significant difference in 5-year overall survival (OS) and disease-free survival (DFS) rates between CCRT and RT groups in both risk categories. However, CCRT patients experienced higher rates of grade ≥ 3 acute hematological toxicities compared to RT patients. The study suggests that for this patient population, CCRT doesn't offer superior outcomes to RT alone and is associated with increased acute toxicities.
Like
Save
Share